Greater hunger and less restraint predict weight loss success with phentermine treatment

Obesity

Volumn 24, Issue 1, 2016, Pages 37-43

  Thomas, Elizabeth A ^a,b   McNair, Bryan ^c   Bechtell, Jamie L ^a,b   Ferland, Annie ^a   Cornier, Marc Andre ^a,b   Eckel, Robert H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Food Science and Human Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENTERMINE;

ADULT; APPETITE; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIET RESTRICTION; FEEDING BEHAVIOR; FEMALE; HUMAN; HUMAN EXPERIMENT; HUNGER; MALE; MORNING DOSAGE; NORMAL HUMAN; OBSERVATIONAL STUDY; PILOT STUDY; THREE-FACTOR-EATING-QUESTIONNAIRE; WEIGHT REDUCTION; CLINICAL TRIAL; DRUG EFFECTS; MEAL; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; APPETITE; BREAKFAST; FEEDING BEHAVIOR; FEMALE; HUMANS; HUNGER; MALE; MIDDLE AGED; OBESITY; PHENTERMINE; PILOT PROJECTS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84951908943     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21244     Document Type: Article

References (36)

1. Ng M, Fleming T, Robinson M, et al., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781.
2. Jensen MD, Ryan DH, Donato KA, et al., Guidelines (2013) for managing overweight and obesity in adults. Obesity 2014; 22: S1-S410.
3. Ayyad C, Andersen T., Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999. Obes RevOff J Int Assoc Stud Obes 2000; 1: 113-119.
4. Wadden TA, Butryn ML, Byrne KJ., Efficacy of lifestyle modification for long-term weight control. Obes Res 2004; 12 (Suppl): 151S-162S.
5. Eckel RH., Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 2008; 358: 1941-1950.
6. Colman E., Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann Inter Med 2005; 143: 380-385.
7. Stafford RS, Radley DC., National trends in antiobesity medication use. Arch Inter Med 2003; 163: 1046-1050.
8. Rothman RB, Baumann MH, Dersch CM, et al., Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 2001; 39: 32-41.
9. Munro JF, MacCuish AC, Wilson EM, Duncan LJ., Comparison of continuous and intermittent anorectic therapy in obesity. Br Med J 1968; 1: 352-354.
10. Truant AP, Olon LP, Cobb S., Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study. Curr Therap Res ClinExp 1972; 14: 726-738.
11. Campbell CJ, Bhalla IP, Steel JM, Duncan LJ., A controlled trial of phentermine in obese diabetic patients. Practitioner 1977; 218: 851-855.
12. Valle-Jones JC, Brodie NH, O'Hara H, O'Hara J, McGhie RL., A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice. Pharmatherapeutica 1983; 3: 300-304.
13. Bray GA., Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab 2008; 93: S81-S88.
14. Kaplan LM., Pharmacologic therapies for obesity. Gastroenterol Clin North Am 2010; 39: 69-79.
15. Hendricks EJ, Greenway FL, Westman EC, Gupta AK., Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 2011; 19: 2351-2360.
16. Kim KK, Cho HJ, Kang HC, Youn BB, Lee KR., Effects on weight reduction and safety of short-term phentermine administration in Korean obese people. Yonsei Med J 2006; 47: 614-625.
17. Ryan DH, Bray GA., Pharmacologic treatment options for obesity: what is old is new again. Curr Hypertension Rep 2013; 15: 182-189.
18. Kim HO, Lee JA, Suh HW, et al., Postmarketing surveillance study of the efficacy and safety of phentermine in patients with obesity. Korean J Fam Med 2013; 34: 298-306.
19. Kang JG, Park CY, Kang JH, Park YW, Park SW., Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity. Diabet Obes Metab 2010; 12: 876-882.
20. Grundy SM, Cleeman JI, Daniels SR, et al., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
21. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE., The eating attitudes test: psychometric features and clinical correlates. Psychol Med 1982; 12: 871-878.
22. Cornier MA, Grunwald GK, Johnson SL, Bessesen DH., Effects of short-term overfeeding on hunger, satiety, and energy intake in thin and reduced-obese individuals. Appetite 2004; 43: 253-259.
23. Stunkard AJ, Messick S., The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosomat Res 1985; 29: 71-83.
24. Flint A, Raben A, Blundell JE, Astrup A., Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38-48.
25. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX., The use of areas under curves in diabetes research. Diabet Care 1995; 18: 245-250.
26. Stubbs RJ, Hughes DA, Johnstone AM, et al., The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr 2000; 84: 405-415.
27. Drapeau V, Blundell J, Therrien F, Lawton C, Richard D, Tremblay A., Appetite sensations as a marker of overall intake. Br J Nutr 2005; 93: 273-280.
28. Drapeau V, King N, Hetherington M, Doucet E, Blundell J, Tremblay A., Appetite sensations and satiety quotient: predictors of energy intake and weight loss. Appetite 2007; 48: 159-166.
29. Thomas EA, Bechtell JL, Vestal BE, et al., Eating-related behaviors and appetite during energy imbalance in obese-prone and obese-resistant individuals. Appetite 2013; 65C: 96-102.
30. Dykes J, Brunner EJ, Martikainen PT, Wardle J., Socioeconomic gradient in body size and obesity among women: the role of dietary restraint, disinhibition and hunger in the Whitehall II study. Int J Obes Relat Metab Disord 2004; 28: 262-268.
31. Provencher V, Drapeau V, Tremblay A, Despres JP, Lemieux S., Eating behaviors and indexes of body composition in men and women from the Quebec family study. Obes Res 2003; 11: 783-792.
32. Aurelie L, Gilles F, Jean-Jacques D, et al., Characterization of the three-factor eating questionnaire scores of a young French cohort. Appetite 2012; 59: 385-390.
33. Hays NP, Bathalon GP, McCrory MA, Roubenoff R, Lipman R, Roberts SB., Eating behavior correlates of adult weight gain and obesity in healthy women aged 55-65 y. Am J Clin Nutr 2002; 75: 476-483.
34. Williamson DA, Lawson OJ, Brooks ER, et al., Association of body mass with dietary restraint and disinhibition. Appetite 1995; 25: 31-41.
35. Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA., Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol 2010; 6: 255-269.
36. Knowler WC, Barrett-Connor E, Fowler SE, et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.